Viewing Study NCT05876351


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-06-02 @ 2:14 AM
Study NCT ID: NCT05876351
Status: COMPLETED
Last Update Posted: 2025-12-08
First Post: 2023-05-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atypical Hemolytic Uremic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None atypical hemolytic uremic View
None aHUS View